Protagenic Therapeutics, Inc. Warrant
PTIXW
PTIXW
3 hedge funds and large institutions have $1.94K invested in Protagenic Therapeutics, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GS
GTS Securities
New York
|
$378 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$1 |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WAM
1
Warberg Asset Management
Winnetka,
Illinois
| $1.56K | – | – | – |
|
|
GS
2
GTS Securities
New York
| $378 | +$378 | +25,200 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1 | +$1 | +100 | New |
|